The Latest Cardiac and Vascular News
vMap’s use with ‘Unmappable’ Ventricular Tachycardia Ablation and Accurate Proof-of-Concept Mapping Using Outpatient 12-lead ECG Data to be Presented at the Heart Rhythm Society’s Annual Conference in New Orleans. NEW ORLEANS–(BUSINESS WIRE)–Vektor Medical, pioneers of the world’s first technology to […]
Targeted, driver-site ablation in conjunction with pulmonary vein isolation (PVI) achieves 87.5% freedom from atrial fibrillation (AF) and atrial tachycardia (AT) in complex AF patients versus 58.0% for PVI-only control SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, developer of the world’s only technology […]
SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, developer of the world’s first technology to rapidly map cardiac arrhythmias using only 12-lead ECG data, today announced it presented new data on its vMap® technology that demonstrated potential utility in patients with adult congenital heart disease […]
Positive efficiency results presented at American College of Physicians Southern California Chapters 1, 2, 3 Poster Competition and Scientific Program SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, the developer of the world’s first technology to rapidly map cardiac arrhythmias using only 12-lead ECG […]
SAN FRANCISCO–(BUSINESS WIRE)–Vektor Medical today announced positive results from its “Vektor vMap™ Clinical Validation Study” evaluating the accuracy of cardiac mapping with vMap™. The study achieved statistically significant results of 98.7% in accurately identifying the regional arrhythmia source location for premature […]
Non-Invasive Technology Requires No Vests, CT or MRI Imaging, or Invasive Mapping SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for its novel computational ECG mapping system, vMap™. vMap is designed to map […]
An article published by the Heart Rhythm Society’s journal Heart Rhythm O2 concludes that Vektor’s Computational ECG Mapping System (vMap™) and protocol-based respiratory gating may help facilitate radioablation planning and maintain efficacy during therapy. CARLSBAD, Calif.–(BUSINESS WIRE)–Vektor Medical, Inc., a private company […]
A dual-center study from UCSD Health and Mills-Peninsula Sutter Health concluded that a simplified, non-invasive radio-ablation workflow, involving vMap™, was Feasible, Efficient, and Precise CARLSBAD, Calif.–(BUSINESS WIRE)–Vektor Medical, Inc. announced that a dual-center study reports that vMap™, as part of a […]
vMap™ was presented as a technology that was able to provide arrhythmia insights for patients following COVID-19 infection, beyond those available from a standard 12-lead ECG CARLSBAD, Calif.–(BUSINESS WIRE)–Vektor Medical, Inc. announced that a single-center study conducted at the University of […]
